Delivery Order SPE2DR25D7058-SPE2DR26F8DSK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,046.01 to AmerisourceBergen Drug Corp for the supply of Potassium Phosphate 45 mmol/15 ml in 15 ml units. This competitively awarded, firm fixed-price delivery order was issued on January 8, 2026, with a completion date of January 9, 2026. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger...
- The Defense Logistics Agency awarded a delivery order valued at $7,184.64 to AmerisourceBergen Drug Corp for the supply of Potassium Phosphate 45 mmol/15 ml in 15 ml units. This is a firm fixed price delivery order with an ultimate completion date of September 19, 2025, and no set-aside designation was used in the award. The vendor will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for potassium phosphate 45 mmol/15 ml in 15 ml units on January 5, 2026, with a ceiling value of $1,280.42 and completion date of January 6, 2026. This firm fixed price, non-set-aside delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for potassium phosphate 45 mmol/15 ml pharmaceutical supplies, valued at $2,458.48 under a firm fixed-price contract with an ultimate completion date of December 26, 2025. This non-set-aside delivery order is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is...
- The Defense Logistics Agency awarded a $3,390.17 delivery order to AmerisourceBergen Drug Corp for potassium phosphate 45 mmol/15 ml pharmaceutical product on August 5, 2025, with ultimate completion targeted for August 6, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $1,385.30 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Potassium Phosphate 15 mmol/5 ml in 5 ml vials. This firm fixed-price contract, with an ultimate completion date of August 15, 2025, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was not set aside and represents a competitive procurement action under the company's existing contract vehicle with the agency. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,119.11 to AmerisourceBergen Drug Corp for the supply of Potassium Phosphate 15 mmol/5 ml in 5 ml vials. This firm fixed-price, competitively awarded delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents no set-aside designation and falls under standard...
- The Defense Logistics Agency awarded a $4,858.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Potassium Phosphate 15 mmol/5 mL in 5 mL vials. The contract, which is classified as a non-set-aside competitive award, has an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,300 to AmerisourceBergen Drug Corp for the supply of Potassium Phosphate 45 mmol/15 ml vials on December 23, 2025, with an ultimate completion date of December 24, 2025. This non-set-aside contract was awarded through competitive procedures on a firm fixed price basis. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) worth $13,354.79 to provide 4563690106 - Potassium Phosphate 150 mmol/50 ml, a pharmaceutical product, with a completion date of February 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31, 2025,...
- SPE2DR25D7058Indefinite Delivery Contract
- SPE2DR25D7058-SPE2DR26F8DSKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,640.00 to AmerisourceBergen Drug Corp for the supply of Potassium Phosphate 45 mmol/15 ml pharmaceutical product. The award was made on January 16, 2026, with an ultimate completion date of January 20, 2026, and is structured as a firm fixed-price contract with no set-aside designation. Performance will take place at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The underlying IDC vehicle enables the company to fulfill pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a global scale, with this specific delivery order representing a routine replenishment of essential pharmaceutical inventory for military treatment facilities and related federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 1/15/26 |